Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Zhaoke Ophthalmology Ltd. ( (HK:6622) ) just unveiled an update.
Zhaoke Ophthalmology Limited has obtained a medical device registration certificate for its innovative tonometer, TONO-i, from the National Medical Products Administration. TONO-i is designed to be a contactless, portable, and convenient tool for measuring intraocular pressure, enhancing the company’s glaucoma franchise by addressing low diagnosis and treatment rates in China. The device is expected to improve patient compliance with glaucoma treatments by providing instant feedback on drug efficacy. The company has an exclusive distribution agreement with C&V Tech, extending its rights to market TONO-i in Greater China, Thailand, and Malaysia.
More about Zhaoke Ophthalmology Ltd.
Zhaoke Ophthalmology Limited is a company incorporated in the British Virgin Islands and continued in the Cayman Islands, focusing on the ophthalmology industry. It specializes in innovative medical devices and treatments for eye conditions, with a particular emphasis on glaucoma management in China and other Asian markets.
Average Trading Volume: 3,050,884
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.56B
For an in-depth examination of 6622 stock, go to TipRanks’ Overview page.